Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
- Resource Type
- Source
- Leukemia
- Subject
Cancer Research 2019-20 coronavirus outbreak Letter Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Siltuximab chemistry.chemical_compound Antineoplastic Agents, Immunological Medical research Humans Medicine Prospective Studies Interleukin 8 Pentraxin-3 Ventilators, Mechanical SARS-CoV-2 business.industry Interleukin-8 Antibodies, Monoclonal COVID-19 Correction Hematology COVID-19 Drug Treatment Survival Rate Serum Amyloid P-Component C-Reactive Protein Oncology chemistry Acute Disease Immunology Infectious diseases business - Language
- ISSN
- 1476-5551
0887-6924